Caffeine is known for its capacity to mitigate performance decrements. The metabolic side-effects are less well understood. This study examined the impact of cumulative caffeine doses on glucose metabolism, self-reported hunger and mood state during 50 hr of wakefulness. In a double-blind laboratory study, participants were assigned to caffeine (n = 9, 6M, age 21.3 AE 2.1 years; body mass index and stress (p < 0.001) on the second day of extended wake compared with day 1.
| INTRODUCTION
Sustained operations, where work hours extend beyond 24 hr, are common in the military, emergency and healthcare services (Krueger, 1989) , and result in sleep loss. Sleep deprivation affects physiological processes, including cardiovascular, endocrine and metabolic systems (Mullington, Haack, Toth, Serrador, & Meier-Ewert, 2009 ). Laboratory studies have shown that sleep deprivation leads to impaired metabolism, including decreased glucose tolerance (Wehrens, Hampton, Finn, & Skene, 2010) and decreased insulin sensitivity (Gonzalez-Ortiz, Martinez-Abundis, Balcazar-Munoz, & Pascoe-Gonzalez, 2000) in humans. With recurring short periods of sleep deprivation, these acute changes in glucose metabolism increase the risk of chronic diseases such as metabolic syndrome (Reiter, Tan, Korkmaz, & Ma, 2012) , obesity and type 2 diabetes (Cappuccio, D'elia, Strazzullo, & Miller, 2010) .
In addition to the detrimental metabolic effects, it is well known that sleep deprivation increases self-reported negative mood states (Durmer & Dinges, 2005) , including increased tiredness (Williamson & Feyer, 2000) , reduced mental sharpness (Durmer & Dinges, 2005) and greater stress (Dinges et al., 1997) . Other subjective changes include greater feelings of hunger (Schmid, Hallschmid, Jauch-Chara, Born, & Schultes, 2008; Spiegel, Tasali, Penev, & Van Cauter, 2004) , which coincides with increased circulating ghrelin levels (hunger hormone). Increased feelings of hunger may also be a result of central glucose utilization being increased during periods of wake (Knutson, 2007) , reflecting higher energy demand of the brain.
Caffeine is a stimulant regularly used to mitigate fatigue and performance deficits during sustained operations, with widely acknowledged benefits for performance (Kamimori, Johnson, Thorne, & Belenky, 2005; McLellan et al., 2005) , and ratings of tiredness and mental sharpness (Penetar et al., 1993) . However, high doses of caffeine in this study (300 and 600 mg per 70 kg) resulted in significantly increased self-reported anxiety and nervousness. It is important to note that participants in this study were administered caffeine via a single dose at 08:00 hours, which does not reflect how caffeine is typically consumed (Brice & Smith, 2002) . Typically caffeine is consumed in a number of doses spaced throughout the day (%3 cups per day) (Drake, Roehrs, Richardson, Walsh, & Roth, 2004 ).
The impact of caffeine during sustained operations on other physiological functions such as glucose metabolism has been largely unexplored. Independent of sleep deprivation, studies have suggested, in both healthy and obese individuals, that a single dose of caffeine increases postprandial glucose and insulin area under the curve (AUC) in comparison to a control (Beaudoin, Robinson, & Graham, 2011; Robinson et al., 2004) .
Caffeine has been shown to reduce subsequent energy intake, suggesting that it may suppress appetite (Yoshioka, Doucet, Drapeau, Dionne, & Tremblay, 2007) . However, these studies have not included subjective hunger ratings. Laboratory studies have shown no impact of caffeine on self-rated hunger (Gavrieli et al., 2013; Schubert et al., 2014) . Given the known impact of sleep deprivation on hunger, further investigation into any cumulative effect of caffeine is needed. Therefore, the primary aim of the current study was to determine the cumulative effect of 200 mg of caffeine, administered in 2-hr intervals throughout the night (01:00 hours, 03:00 hours, 05:00 hours and 07:00 hours), on glucose response to breakfast during extended wake (24 hr/49 hr). A secondary aim was to determine the impact of high-dose caffeine on hunger and mood state during extended wake.
| MATERIALS AND METHODS
This 4-day, double-blind, placebo-controlled study was conducted in the sleep laboratory at the Centre for Sleep Research at the University of South Australia, Adelaide, Australia.
| Participants
Healthy young adults, aged 18-40 years, were recruited via flyers in the local community and online. Respondents underwent detailed screening sessions to ensure they met strict inclusion/exclusion criteria. Inclusion criteria were: good health (confirmed by a confidential medical screening, fasting blood test and Beck Depression Inventory; (Beck, Steer, & Brown, 1996) ; body mass index (BMI) greater than 18 kg/m 2 and less than 30 kg/m 2 (with stable weight over the preceding 3 months); stable habitual sleep duration between 7 and 9 hr a night (confirmed using self-reported sleep/ wake diaries, and wrist-worn activity monitors (Actiwatch 2; Philips Respironics, Bend, OR, USA) in the 2 weeks prior to the study); and resting blood pressure does not exceed 140/90 or resting pulse >110. Exclusion criteria were: engagement in night shift-work; transmeridian travel; smoking or illicit drug use; excessive alcohol (>2 standard drinks per day) or caffeine consumption (>2 cups per day) in the 2 months prior to the study; use of prescription or over-thecounter medications known to affect glucose metabolism or sleep; extreme morningness-eveningness (confirmed via the composite morningness-eveningness scale; score of <31 or >69); or pregnant.
Enrolled participants were instructed to abstain from caffeine and alcohol in the week prior to the study.
Approval was granted by the University of South Australia
Human Research Ethics Committee (0000031553). Written consent was obtained prior to commencement and participants were aware they could withdraw at any time. Participants were compensated financially for their time.
| Procedure
Participants remained in the laboratory for the duration of the protocol, and were not permitted access to clocks or social time cues (i.e. mobile phones, internet and live television). Environmental conditions in the laboratory were maintained at a constant, ambient temperature 23 AE 1°C. The laboratory is windowless and sound attenuated.
A detailed study protocol is shown in Figure 1 . On day 1, participants were familiarized with the laboratory environment and the cognitive test batteries. To ensure they obtained a minimum of 8 hr sleep prior to the 50 hr of extended wake, participants were given a 10 hr baseline sleep opportunity from 22:00 hours to 08:00 hours (<0.03 lux). Participants then began 50 hr of extended wake (day 1; 08:00 hours to day 3; 10:00 hours, <50 lux). Throughout the extended wake period, participants completed cognitive test batteries at regular intervals, results published elsewhere Pajcin et al., 2017) . Meal tolerance tests were completed at breakfast on days 2-4. When not completing scheduled tasks, participants were free to read, watch DVDs, play board games, and interact in the shared living space. Participants were not permitted to engage in vigorous exercise. Study personnel monitored participants throughout the protocol to ensure compliance. On completion of the extended wake, participants were given a 9 hr daytime recovery sleep opportunity (10:00 hours-19:00 hours).
| Caffeine administration
Participants were randomly assigned to placebo (control) or caffeine (intervention) conditions via drawing of lots. Allocation was done at the group level, with up to four participants completing the study simultaneously. The project CI was responsible for gum allocation (MarketRight, Plano, IL, USA), administered at 01:00 hours, 03:00 hours, 05:00 hours and 07:00 hours on days 1 and 2 of the extended wake protocol. Neither the participants nor the research staff working with them were aware of the allocation of active or placebo gum (double-blind). Participants were instructed to chew two pellets of gum concurrently for a minimum of 5 min prior to expectorating, allowing at least 85% of caffeine to be released (Kamimori et al., 2002) . Gum administration was observed by research staff to ensure compliance. Each pellet contained 100 mg of caffeine, amounting to a potential total of 800 mg of caffeine per day. Serum caffeine levels were measured to ensure effective delivery. Characteristics (colour, taste and aroma) of the placebo pellet were identical. The pellets contained: sugar, gum base, dextrose, corn syrup, artificial and natural flavours, caffeine (omitted in placebo), glycerine, sucralose, maltodextrin, aspartame (contains phenylalanine), artificial colours, resinous glaze, carnauba wax, BHT, soy lecithin. The only difference in the protocol between conditions was the administration of caffeine or placebo.
| Dietary intake
Food intake was controlled throughout the study, with meals at 07:00 hours-08:00 hours (breakfast), 13:00 hours (lunch),
19:00 hours (dinner), 01:00 hours (snack). All food intake was prepared and served in the shared living space, and recorded at the time of consumption. Between meal times, participants were allowed water and decaffeinated tea ad libitum. Food was restricted to meal times only. The macronutrient content of meals was based on the average Australian diet (Australian Bureau of Statistics, 1997), shown in Table 1 .
| Meal tolerance test (breakfast)
Meal tolerance tests were conducted post-breakfast (0-120 min) each day, using Medtronic continual glucose monitors, which have been used regularly in clinical settings and validated against plasma glucose (Sachedina & Pickup, 2003) . The meal tolerance test was chosen to simulate a naturalistic metabolic challenge. Participants consumed a breakfast meal, which included a cereal, fruit juice, skim milk and fruit ( Table 2 ). The continual glucose monitor measures interstitial glucose via a small, flexible wire sensor inserted in the subcutaneous layer of skin near the navel. The sensor provides a reading every 5 min. The devices were calibrated using a pre-set lancet to collect finger-prick blood samples three to four times a day. Measures were taken during recruitment, within the overall laboratory environment and during the meal tolerance test to minimize factors other than sleep deprivation and caffeine affecting glucose response. Participants recruited were healthy, non-obese and psychologically healthy, had a normal fasting glucose, and did not use prescription medication known to affect glucose tolerance.
The overall laboratory environment was controlled to minimize stress, including prohibiting exercise and steering conversations away from topics that may distress participants. Food intake was controlled throughout the protocol, and movement was limited during the meal tolerance test, with reduced interaction during this time.
F I G U R E 1 Protocol schematic. Black bars; scheduled sleep opportunities (<3 lux), white bars; periods of wake (<50 lux), grey box; blood testing in response to breakfast meal, navy box; meal times, stars; caffeine gum administration (200 mg), squares; hunger/mood ratings GRANT ET AL. 
| Sleep data
Sleep was recorded at baseline (22:00 hours-08:00 hours) and recovery (10:00 hours-19:00 hours), using standard polysomnography with Compumedics GRAEL recorders (Melbourne, Australia). A standard montage of F3, F4, C3, C4, referenced to contralateral mastoids (M1, M2) was used. Sleep was scored according to Rechtschaffen and Kales sleep staging criteria (Rechtschaffen & Kales, 1968 
| Statistical analyses
Analyses were completed using SPSS 21.0 software (IBM, Armonk, NY, USA). Independent sample t tests examined differences between conditions for age, BMI and habitual sleep prior to entry into the sleep laboratory. The baseline sleep (day 1) was analysed using independent sample t tests to examine differences between conditions at baseline.
To assess interstitial glucose response to breakfast, AUC was calculated (0-120 min post-breakfast, 5-min intervals) using the trapezoidal estimation method (Le Floch, Escuyer, Baudin, Baudon, & Perlemuter, 1990) . Mixed-effects ANOVAs analysed AUC with fixed effects of condition (caffeine, placebo) and day (day 1, day 2, day 3), and their interaction (condition 9 day), and a random effect of the subject identifier on the intercept. Post hoc pairwise comparisons were conducted to further examine significant effects.
Mixed-effects ANOVAs were also used to analyse the hunger and mood state variables, looking specifically at pre-(22:30 hours) and during caffeine intake (04:00 hours) on days 1 and 2, with mixed effects of condition (caffeine, placebo), day (day 1, day 2) and time (pre-, during), and their interaction (condition 9 day, condition 9 time, condition 9 day 9 time), and a random effect of the subject identifier on the intercept.
Effect sizes (partial eta squared) for all outcome measures were estimated, with small, medium and large effect thresholds set at 0.01, 0.06 and 0.14, respectively (Richardson, 2011) . Denominator degrees of freedom were corrected with the Satterthwaite approximation and are reported to the nearest whole number. Results were considered statistically significant if p ≤ 0.05 (two-tailed).
3 | RESULTS
| Participants
Twenty-four participants completed this study. Data for four participants were removed, due to a technical failure with the continual glucose monitors. Data from three participants were removed due to limited food intake at breakfast (Consort diagram, Figure 2 ). Data for 17 participants were included in the final analysis, with nine in the caffeine and eight in the placebo condition (participant characteristics are shown in Table 3 ). There were no significant differences in age (p = 0.186), BMI (p = 0.906) or total sleep time (p = 0.274) between conditions.
| Sleep data
The average time in bed at baseline was 598.5 AE 2.0 min and 585.3 AE 18.6 min, with an average total sleep time of 543.5 AE 23.4 min and 532.5 AE 25.5 min in the caffeine and placebo conditions, respectively. There was no significant difference between conditions for any of the sleep variables on day 1 (baseline; Table 4 ).
| Interstitial glucose response to breakfast
There was a significant effect of day on AUC (F 2,30 = 7.081, p = 0.003, ɳ 2 (partial) = 0.321, large effect), with glucose AUC in response to breakfast significantly increased on day 3 compared with day 1 (p = 0.001; Figure 3 ). There was no condition (F 1,15 = 0.177, p = 0.680, ɳ 2 (partial) = 0.012, small effect) or condition 9 day interaction (F 2,30 = 0.454, p = 0.639, ɳ 2 (partial) = 0.029, small effect). Overall, the average glucose AUC response to breakfast was 11% higher on day 2, and 21% higher on day 3 compared with day 1 (baseline). 
T A B L E 1 Actual dietary percentage contribution

| Hunger scales
There were no significant effects for any of the hunger scales (Table 5) .
| Mood state
There was a significant main effect of day, with increased tiredness (Table 5 ). There was a significant condition 9 day interaction, such that caffeine attenuated the rise in tiredness Wehrens et al., 2010) . This is the first study, to our knowledge, that examined the cumulative effect of extended wake and caffeine intake on metabolism. In this study, we found no impact of caffeine on glucose metabolism. This is in contrast to previous studies that have shown that caffeine leads to impaired glucose metabolism (Battram, Arthur, Weekes, & Graham, 2006; Greenberg, Owen, & Geliebter, 2010; Keijzers, De Galan, Tack, & Smits, 2002) . It may be that the impact of extended wakefulness on glucose metabolism is large enough to mask any effects of caffeine. This suggests that the use of caffeine during extended wake to mitigate performance decrements is unlikely to further compromise glucose processing.
Hunger ratings remained stable throughout this study, suggesting neither sleep deprivation nor caffeine intake altered hunger. No previous studies had examined these two variables in conjunction; however, two previous laboratory studies have shown elevated ratings of appetite and hunger in response to sleep loss. These studies also reported significant reductions in leptin (appetite-suppressing hormone) and increases in ghrelin (appetite-inducing hormone) in response to sleep loss (Schmid et al., 2008; Spiegel et al., 2004) . Comparing our study results with prior research is difficult due to a number of factors. We did not measure leptin or ghrelin in this study. The study by Spiegel et al. (2004) involved sleep restriction to 4 hr at night, which may produce different effects to extended wake. The Schmid et al. (2008) study was a total sleep deprivation study; however, participants did not have access to food across the night. In the present study, participants were fed a snack at 01:00 hours, which is common practice in the shift-work population, which may have modulated any rise in hunger ratings. A total sleep deprivation study by Lowden et al. (2001) , where food was provided every 4 hr across the night, reported decreased hunger at night. It is important to keep in mind that other factors affect self-reported feelings of hunger, including habit and boredom rather than hunger alone (Costa, 1996) .
Despite previous research suggesting that caffeine may work as an appetite suppressant due to a reduction in subsequent energy intake following caffeine administration (Tremblay, Masson, Leduc, Houde, & Despr es, 1988; Yoshioka et al., 2007) , we found no impact of caffeine on feelings of hunger, fullness, desire to eat, or thoughts of food. This finding is consistent with other studies examining the effect of caffeine intake on self-rated hunger in the morning, in conjunction with a standard breakfast (Gavrieli et al., 2013; Schubert et al., 2014) .
During the first night of extended wakefulness, caffeine attenuated the self-reported tiredness and irritability and increased mental sharpness relative to the placebo group. This is consistent with T A B L E 5 Linear mixed models: Hunger and mood scales previous studies (Penetar et al., 1993) . Interestingly, on the second night of extended wakefulness, the effectiveness of caffeine weakened, with both conditions reporting similar, elevated feelings of tiredness and irritability and decreased mental sharpness. Importantly, both the Penetar et al. (1993) study and this study used a parallel study design; reporting of mood state may have been different in a crossover study, where participants experience the same level of extended wake with and without caffeine. A crossover design would also account for individual differences in physiological response to caffeine.
Our study focused on the effect of caffeine during sustained wakefulness in a controlled laboratory environment, in a population of previously well-rested, healthy young people. However, shiftworkers who are routinely exposed to sleep loss (Banks, Van Dongen, Maislin, & Dinges, 2010; Lamond et al., 2007) often use caffeine as a countermeasure (Berger & Hobbs, 2006) . It is common for shift-workers to experience acute extended wakefulness, similar to day 1 of our study, as they transition to the night shift (Folkard, 1992) . Subsequent night shifts may result in sleep restriction rather than total sleep deprivation. Therefore, future research should address the effect of caffeine on metabolism, hunger and mood state during periods of sleep restriction. Furthermore, while the benefits of acute caffeine intake on mood state have been shown, it is important to note that ongoing use of a stimulant such as caffeine may result in tolerance, which can lead to ever increasing dosages to induce similar effects (Evans & Griffiths, 1992) . Participants in our study were excluded if they habitually consumed caffeine (>2 cups per day); however, during sustained operations people often consume large amounts of caffeine, which may result in effects that are different from our findings. Fast and slow metabolizers of caffeine may also respond differently, and these groups could be examined in future research.
The effectiveness of caffeine in preventing performance decline and its effect on metabolism is dependent on the dose, the 
| Conclusions
The findings of this study suggest that caffeine gum can be used as a countermeasure to mitigate performance without negatively affecting glucose metabolism (as measured by interstitial glucose response to breakfast), or hunger over and above the impact of sleep deprivation. Caffeine effectively reduced tiredness and irritability, and increased mental sharpness on the first night of extended wakefulness; however, the effectiveness of caffeine was limited with further time awake.
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